We observed the induction of inflammatory signals in the CRC PDOs, including upregulation of IL-6, CXCL6, IL-1B, and TNFAIP6 expression, in response to both treatments (online supplemental figure S7D). The gene discussed is TNFAIP6; the disease is colorectal carcinoma.